The DOI matches its Crossref record; 173 of the 173 references it cites were found in a registry or an index.
Drug Delivery to the Posterior Segment of the Eye: Biopharmaceutic and Pharmacokinetic Considerations
Open accessAbstract
The treatment of the posterior-segment ocular diseases, such as age-related eye diseases (AMD) or diabetic retinopathy (DR), present a challenge for ophthalmologists due to the complex anatomy and physiology of the eye. This specialized organ is composed of various static and dynamic barriers that restrict drug delivery into the target site of action. Despite numerous efforts, effective intraocular drug delivery remains unresolved and, therefore, it is highly desirable to improve the current treatments of diseases affecting the posterior cavity. This review article gives an overview of pharmacokinetic and biopharmaceutics aspects for the most commonly-used ocular administration routes (intravitreal, topical, systemic, and periocular), including information of the absorption, distribution, and elimination, as well as the benefits and limitations of each one. This article also encompasses different conventional and novel drug delivery systems designed and developed to improve drug pharmacokinetics intended for the posterior ocular segment treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Gaudana, R., Ananthula, H. K., Parenky, A., & Mitra, A. K. (2010) · The AAPS Journal · doi:10.1208/s12248-010-9183-3 · Cited by 1,406
Challenges and obstacles of ocular pharmacokinetics and drug delivery
Urtti, A. (2006) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2006.07.027 · Cited by 1,003
Ghasemi Falavarjani, K., & Nguyen, Q. D. (2013) · Eye · doi:10.1038/eye.2013.107 · Cited by 982
Ocular drug delivery systems: An overview
Patel, A. (2013) · World Journal of Pharmacology · doi:10.5497/wjp.v2.i2.47 · Cited by 890
Pharmacokinetic aspects of retinal drug delivery
del Amo, E. M., Rimpelä, A.-K., Heikkinen, E., Kari, O. K., Ramsay, E., Lajunen, T., Schmitt, M., Pelkonen, L., Bhattacharya, M., Richardson, D., et al. (2017) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2016.12.001 · Cited by 693
Pharmacokinetics of Intravitreal Bevacizumab (Avastin)
Bakri, S. J., Snyder, M. R., Reid, J. M., Pulido, J. S., & Singh, R. J. (2007) · Ophthalmology · doi:10.1016/j.ophtha.2007.01.017 · Cited by 683
Permeability of cornea, sclera, and conjunctiva: A literature analysis for drug delivery to the eye
Prausnitz, M. R., & Noonan, J. S. (1998) · Journal of Pharmaceutical Sciences · doi:10.1021/js9802594 · Cited by 627
Recent Perspectives in Ocular Drug Delivery
Gaudana, R., Jwala, J., Boddu, S. H. S., & Mitra, A. K. (2009) · Pharmaceutical Research · doi:10.1007/s11095-008-9694-0 · Cited by 605
Pharmacokinetics of Intravitreal Ranibizumab (Lucentis)
Bakri, S. J., Snyder, M. R., Reid, J. M., Pulido, J. S., Ezzat, M. K., & Singh, R. J. (2007) · Ophthalmology · doi:10.1016/j.ophtha.2007.09.012 · Cited by 541
Stability of nanosuspensions in drug delivery
Wang, Y., Zheng, Y., Zhang, L., Wang, Q., & Zhang, D. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.08.006 · Cited by 492
Scleral structure, organisation and disease. A review
Watson, P. G., & Young, R. D. (2004) · Experimental Eye Research · doi:10.1016/s0014-4835(03)00212-4 · Cited by 407
Topical and systemic drug delivery to the posterior segments
HUGHES, P., OLEJNIK, O., CHANGLIN, J., & WILSON, C. (2005) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2005.09.004 · Cited by 400
(2000) · PubMed · Cited by 358
Mannermaa, E., Vellonen, K.-S., & Urtti, A. (2006) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2006.07.024 · Cited by 349
Drug delivery for posterior segment eye disease.
Geroski, D. H., & Edelhauser, H. F. (2000) · PubMed · Cited by 342
Drug delivery to the posterior segment of the eye
Thrimawithana, T. R., Young, S., Bunt, C. R., Green, C., & Alany, R. G. (2011) · Drug Discovery Today · doi:10.1016/j.drudis.2010.12.004 · Cited by 335
Suprachoroidal drug delivery to the back of the eye using hollow microneedles
Patel, S. R., Lin, A. S. P., Edelhauser, H. F., & Prausnitz, M. R. (2011) · Pharmaceutical Research · doi:10.1007/s11095-010-0271-y · Cited by 330 · cited 3×
“Sulforhodamine B microneedle injection was also studied as well as nanoparticle and microparticle suspensions into the suprachoroidal space [215,222].”
BackgroundMethodMethotrexate for Ocular Inflammatory Diseases
Gangaputra, S., Newcomb, C. W., Liesegang, T. L., Kaçmaz, R. O., Jabs, D. A., Levy-Clarke, G. A., Nussenblatt, R. B., Rosenbaum, J. T., Suhler, E. B., & Thorne, J. E. (2009) · Ophthalmology · doi:10.1016/j.ophtha.2009.04.020 · Cited by 330
Ghate, D., & Edelhauser, H. F. (2006) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.3.2.275 · Cited by 329
Nanoparticle diffusion in, and microrheology of, the bovine vitreous ex vivo
Xu, Q., Boylan, N. J., Suk, J. S., Wang, Y.-Y., Nance, E. A., Yang, J.-C., McDonnell, P. J., Cone, R. A., Duh, E. J., & Hanes, J. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.01.018 · Cited by 326
Ocular novel drug delivery: impacts of membranes and barriers
Barar, J., Javadzadeh, A. R., & Omidi, Y. (2008) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.5.5.567 · Cited by 308
Biodegradable Implants for Sustained Drug Release in the Eye
Lee, S. S., Hughes, P., Ross, A. D., & Robinson, M. R. (2010) · Pharmaceutical Research · doi:10.1007/s11095-010-0159-x · Cited by 289
Interaction Between Chemicals and Melanin
LARSSON, B. S. (1993) · Pigment Cell Research · doi:10.1111/j.1600-0749.1993.tb00591.x · Cited by 287
Transscleral drug delivery for posterior segment disease
Geroski, D. H., & Edelhauser, H. F. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00193-4 · Cited by 282
Permeability of Retinal Pigment Epithelium: Effects of Permeant Molecular Weight and Lipophilicity
Pitka¨nen, L., Ranta, V.-P., Moilanen, H., & Urtti, A. (2005) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.04-1051 · Cited by 261 · cited 2×
“, FITC dextran) can be limited by the vitreous structure [33].”
BackgroundPeriocular routes for retinal drug delivery
Raghava, S., Hammond, M., & Kompella, U. B. (2004) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.1.1.99 · Cited by 257
Patel, S. R., Berezovsky, D. E., McCarey, B. E., Zarnitsyn, V., Edelhauser, H. F., & Prausnitz, M. R. (2012) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.12-9872 · Cited by 241
Kompella, U. B., Bandi, N., & Ayalasomayajula, S. P. (2003) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.02-0791 · Cited by 239
Intraocular implants for extended drug delivery: Therapeutic applications
Bourges, J. L., Bloquel, C., Thomas, A., Froussart, F., Bochot, A., Azan, F., Gurny, R., BenEzra, D., & Behar-Cohen, F. (2006) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2006.07.026 · Cited by 235
del Amo, E. M., & Urtti, A. (2015) · Experimental Eye Research · doi:10.1016/j.exer.2015.05.003 · Cited by 231
Olsen, T. W., Edelhauser, H. F., Lim, J. I., & Geroski, D. H. (1995) · PubMed · Cited by 230
Kwak, H. W. (1992) · Archives of Ophthalmology · doi:10.1001/archopht.1992.01080140115038 · Cited by 228
Overcoming ocular drug delivery barriers through the use of physical forces
Huang, D., Chen, Y.-S., & Rupenthal, I. D. (2018) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2017.09.008 · Cited by 227
The blood–retinal barriers system. Basic concepts and clinical evaluation
Cunha-Vaz, J. G. (2004) · Experimental Eye Research · doi:10.1016/s0014-4835(03)00213-6 · Cited by 214
Novel approaches to retinal drug delivery
Janoria, K. G., Gunda, S., Boddu, S. H., & Mitra, A. K. (2007) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.4.4.371 · Cited by 213
Transscleral delivery of bioactive protein to the choroid and retina.
Ambati, J., Gragoudas, E. S., Miller, J. W., You, T., Miyamoto, K., Delori, F. C., & Adamis, A. P. (2000) · PubMed · Cited by 207
Aminoglycoside Toxicity in the Treatment of Endophthalmitis
Campochiaro, P. A. (1994) · Archives of Ophthalmology · doi:10.1001/archopht.1994.01090130058017 · Cited by 199
Balguri, S. P., Adelli, G. R., & Majumdar, S. (2016) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2016.10.015 · Cited by 195
Comparison of conjunctival and corneal surface areas in rabbit and human
Watsky, M. A., Jablonski, M. M., & Edelhauser, H. F. (1988) · Current Eye Research · doi:10.3109/02713688809031801 · Cited by 192
Acetazolamide: future perspective in topical glaucoma therapeutics
Kaur, I. P., Smitha, R., Aggarwal, D., & Kapil, M. (2002) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(02)00438-6 · Cited by 192
Fluorescein angiography and adverse drug reactions revisited: the Lions Eye experience
Kwan, A. S., Barry, C., McAllister, I. L., & Constable, I. (2006) · Clinical & Experimental Ophthalmology · doi:10.1111/j.1442-9071.2006.01136.x · Cited by 183
Binding of Drugs to Eye Melanin Is Not Predictive of Ocular Toxicity
Leblanc, B., Jezequel, S., Davies, T., Hanton, G., & Taradach, C. (1998) · Regulatory Toxicology and Pharmacology · doi:10.1006/rtph.1998.1243 · Cited by 179
Subretinal injection: a review on the novel route of therapeutic delivery for vitreoretinal diseases
Peng, Y., Tang, L., & Zhou, Y. (2017) · Ophthalmic Research · doi:10.1159/000479157 · Cited by 175 · cited 6×
“Subretinal delivery can also be used for stem cell transplantation in ocular degenerative diseases, which was reported in vivo studies and aimed at clinical applications [224].”
BackgroundMethodInfluentialNanotherapy for posterior eye diseases
Kaur, I. P., & Kakkar, S. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.05.031 · Cited by 175
Barrier analysis of periocular drug delivery to the posterior segment
Ranta, V.-P., Mannermaa, E., Lummepuro, K., Subrizi, A., Laukkanen, A., Antopolsky, M., Murtomäki, L., Hornof, M., & Urtti, A. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.08.028 · Cited by 173
Complications of intravitreal injection of triamcinolone acetonide
Özkiriş, A., & Erkiliç, K. (2005) · Canadian Journal of Ophthalmology · doi:10.1016/s0008-4182(05)80119-x · Cited by 172
Cannulation of the suprachoroidal space: a novel drug delivery methodology to the posterior segment
Olsen, T. W., Feng, X., Wabner, K., Conston, S. R., Sierra, D. H., Folden, D. V., Smith, M. E., & Cameron, J. D. (2006) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2006.05.045 · Cited by 171 · cited 2×
“This administration route was tested for drug delivery into the posterior segment of the eye employing surgical procedures (by introducing catheters into this space) and gave rise to a long-term therapy, where drugs could be targeted towards the choroid and retina by direct contact with the administration site [218,21…”
MethodMYLES, M., NEUMANN, D., & HILL, J. (2005) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2005.08.006 · Cited by 171
Davis, B. M., Normando, E. M., Guo, L., Turner, L. A., Nizari, S., O'Shea, P., Moss, S. E., Somavarapu, S., & Cordeiro, M. F. (2014) · Small · doi:10.1002/smll.201303433 · Cited by 164
Amrite, A. C., Ayalasomayajula, S. P., Cheruvu, N. P. S., & Kompella, U. B. (2006) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.05-0531 · Cited by 162
Transscleral drug delivery to the posterior eye: Prospects of pharmacokinetic modeling
Ranta, V.-P., & Urtti, A. (2006) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2006.07.025 · Cited by 160
Ayalasomayajula, S. P., & Kompella, U. B. (2002) · European Journal of Pharmacology · doi:10.1016/s0014-2999(02)02793-0 · Cited by 159
Ramsay, E., del Amo, E. M., Toropainen, E., Tengvall, U., Ranta, V., Urtti, A. O., & Ruponen, M. (2018) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2018.03.034 · Cited by 159
Intravitreal Sustained-Release Ganciclovir
Smith, T. J. (1992) · Archives of Ophthalmology · doi:10.1001/archopht.1992.01080140111037 · Cited by 157
Pharmacokinetics of Intravitreal Anti-VEGF Drugs in Age-Related Macular Degeneration
García‐Quintanilla, L., Luaces-Rodríguez, A., Gil‐Martínez, M., Mondelo‐García, C., Maroñas, O., Sanjuan, V. M., González‐Barcia, M., Zarra‐Ferro, I., Aguiar, P., Otero-Espinar, F. J., et al. (2019) · Pharmaceutics · doi:10.3390/pharmaceutics11080365 · Cited by 156
Self-citationReview: Practical Issues in Intravitreal Drug Delivery
Maurice, D. M. (2001) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/108076801753162807 · Cited by 153
Permeability and Diffusion in Vitreous Humor: Implications for Drug Delivery
Xu, J., Heys, J. J., Barocas, V. H., & Randolph, T. W. (2000) · Pharmaceutical Research · doi:10.1023/a:1007517912927 · Cited by 147
Cardillo, J. A., Melo, L. A. S., Costa, R. A., Skaf, M., Belfort, R., Filho, A. A. D. S. L., Farah, M. E., & Kuppermann, B. D. (2005) · Ophthalmology · doi:10.1016/j.ophtha.2005.03.023 · Cited by 147
Proteomic analysis of human vitreous humor
Murthy, K. R., Goel, R., Subbannayya, Y., Jacob, H. K., Murthy, P. R., Manda, S. S., Patil, A. H., Sharma, R., Sahasrabuddhe, N. A., Parashar, A., et al. (2014) · Clinical Proteomics · doi:10.1186/1559-0275-11-29 · Cited by 145
Niwa, Y., Kakinoki, M., Sawada, T., Wang, X., & Ohji, M. (2015) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.15-17279 · Cited by 145
In vitro and ex vivo models to study drug delivery barriers in the posterior segment of the eye
Peynshaert, K., Devoldere, J., Smedt, S. C. D., & Remaut, K. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2017.09.007 · Cited by 143
Ayalasomayajula, S. P., & Kompella, U. B. (2005) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2005.02.019 · Cited by 141
Hosoya, K., & Tomi, M. (2005) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.28.1 · Cited by 140
Quantitative Proteomics Analysis of Vitreous Humor from Diabetic Retinopathy Patients
Loukovaara, S., Nurkkala, H., Tamene, F., Gucciardo, E., Liu, X., Repo, P. E., Lehti, K., & Varjosalo, M. T. (2015) · Journal of Proteome Research · doi:10.1021/acs.jproteome.5b00900 · Cited by 139
Kim, H. C., Robinson, M. R., Lizak, M. J., Tansey, G., Lutz, R. J., Yuan, P., Wang, N. S., & Csaky, K. G. (2004) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.04-0091 · Cited by 129
Dafflon, M. L., Tran, V. T., Guex‐Crosier, Y., & Herbort, C. P. (1999) · Graefe s Archive for Clinical and Experimental Ophthalmology · doi:10.1007/s004170050235 · Cited by 127
Distribution of Brimonidine into Anterior and Posterior Tissues of Monkey, Rabbit, and Rat Eyes
Acheampong, A., Shackleton, M., John, B. A., Burke, J. E., Wheeler, L. A., & Tang-Liu, D. D.-S. (2002) · Drug Metabolism and Disposition · doi:10.1124/dmd.30.4.421 · Cited by 126
Toda, R., Kawazu, K., Oyabu, M., Miyazaki, T., & Kiuchi, Y. (2011) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.22610 · Cited by 123
Role of Metabolism in Ocular Drug Delivery
Duvvuri, S., Majumdar, S., & Mitra, A. K. (2004) · Current Drug Metabolism · doi:10.2174/1389200043335342 · Cited by 122
Sigurðsson, H. H., Konrádsdóttir, F., Loftsson, Þ., & Stefánsson, E. (2007) · Acta Ophthalmologica Scandinavica · doi:10.1111/j.1600-0420.2007.00885.x · Cited by 122
Hussain, A. A., Starita, C., Hodgetts, A., & Marshall, J. J. T. (2010) · Experimental Eye Research · doi:10.1016/j.exer.2010.02.013 · Cited by 121
Drug and Gene Delivery to the Back of the Eye: From Bench to Bedside
Rowe-Rendleman, C. L., Durazo, S. A., Kompella, U. B., Rittenhouse, K. D., Di Polo, A., Weiner, A. L., Grossniklaus, H. E., Naash, M. I., Lewin, A. S., Horsager, A., et al. (2014) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.13-13707 · Cited by 120 · cited 1×
“Subconjunctival placement of insulin-impregnated hydrogels has presented advantages over topical and intravitreal injection in DR treatment [197,198].”
BackgroundTransscleral drug delivery to the retina and choroid
Ambati, J., & Adamis, A. P. (2002) · Progress in Retinal and Eye Research · doi:10.1016/s1350-9462(01)00018-0 · Cited by 119
Shen, J., Deng, Y., Jin, X., Ping, Q., Su, Z., & Li, L. (2010) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2010.10.008 · Cited by 116
Diffusion Regulation in the Vitreous Humor
Käsdorf, B. T., Arends, F., & Lieleg, O. (2015) · Biophysical Journal · doi:10.1016/j.bpj.2015.10.002 · Cited by 116
Undefined role of mucus as a barrier in ocular drug delivery
Ruponen, M., & Urtti, A. O. (2015) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2015.02.032 · Cited by 112
Stay, M. S., Xu, J., Randolph, T. W., & Barocas, V. H. (2003) · Pharmaceutical Research · doi:10.1023/a:1022207026982 · Cited by 111
Loftsson, Þ., Hreinsdóttir, D., & Stefánsson, E. (2007) · Journal of Pharmacy and Pharmacology · doi:10.1211/jpp.59.5.0002 · Cited by 110
Subretinal injections in rodent eyes: effects on electrophysiology and histology of rat retina.
Timmers, A. M., Zhang, H., Squitieri, A., & Gonzalez-Pola, C. (2001) · PubMed · Cited by 110
Cheruvu, N. P. S., & Kompella, U. B. (2006) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.06-0404 · Cited by 107
Park, J., Bungay, P. M., Lutz, R. J., Augsburger, J. J., Millard, R. W., Roy, A. S., & Banerjee, R. K. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.03.010 · Cited by 107
The Blood-Aqueous Barrier in Health and Disease
Coca‐Prados, M. (2014) · Journal of Glaucoma · doi:10.1097/ijg.0000000000000107 · Cited by 106
Inner Blood-Retinal Barrier Transporters: Role of Retinal Drug Delivery
Hosoya, K., & Tachikawa, M. (2009) · Pharmaceutical Research · doi:10.1007/s11095-009-9930-2 · Cited by 105
Posterior sub-Tenon's triamcinolone injections in the treatment of uveitis
Tanner, V., Kanski, J. J., & FRITH, P. A. (1998) · Eye · doi:10.1038/eye.1998.168 · Cited by 104
Evaluation of a novel biomaterial in the suprachoroidal space of the rabbit eye.
Einmahl, S., Savoldelli, M., D'Hermies, F., Tabatabay, C., Gurny, R., & Béhar‐Cohen, F. (2002) · PubMed · Cited by 102
Drug delivery to the posterior segment of the eye for pharmacologic therapy
Shah, S., Denham, L. V., Elison, J. R., Bhattacharjee, P. S., Clément, C., Huq, T. S., & Hill, J. M. (2010) · Expert Review of Ophthalmology · doi:10.1586/eop.09.70 · Cited by 102
Molecular Design for Enhancement of Ocular Penetration
Shirasaki, Y. (2007) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21200 · Cited by 101
Kakinoki, M., Sawada, O., Sawada, T., Saishin, Y., Kawamura, H., & Ohji, M. (2012) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.12-10164 · Cited by 99
Friedrich, S. W., Cheng, Y., & Saville, B. A. (1997) · Current Eye Research · doi:10.1076/ceyr.16.7.663.5061 · Cited by 97
Pharmacokinetics of intravitreal antibiotics in endophthalmitis
Medikonda, R., Mithal, K., Bawdekar, A. C., Dave, V. P., Jindal, A., Relhan, N., Albini, T. A., Pathengay, A., & Flynn, H. W. (2014) · Journal of Ophthalmic Inflammation and Infection · doi:10.1186/s12348-014-0022-z · Cited by 95
Proteomic Analyses of the Vitreous Humour
Angi, M., Kalirai, H., Coupland, S. E., Damato, B. E., Semeraro, F., & Romano, M. R. (2012) · Mediators of Inflammation · doi:10.1155/2012/148039 · Cited by 95
Misra, G. P., Singh, R. S., Alemán, T. S., Jacobson, S. G., Gardner, T. W., & Lowe, T. L. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2009.08.025 · Cited by 95
Pharmacokinetics of intravitreal anti-VEGF drugs in vitrectomized versus non-vitrectomized eyes
Edington, M., Connolly, J., & Chong, V. N. (2017) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2017.1404987 · Cited by 95
Kambhampati, S. P., Clunies-Ross, A. J., Bhutto, I. A., Mishra, M. K., Edwards, M. M., McLeod, D. S., Kannan, R. M., & Lutty, G. A. (2015) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.14-16250 · Cited by 94
The Future of Uveitis Treatment
Lin, P., Suhler, E. B., & Rosenbaum, J. T. (2013) · Ophthalmology · doi:10.1016/j.ophtha.2013.08.029 · Cited by 93
Pharmacokinetics of Intraocular Drug Delivery by Periocular Injections Using Ocular Fluorophotometry
Ghate, D. A., Brooks, W., McCarey, B. E., & Edelhauser, H. F. (2007) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.06-0954 · Cited by 93
Kinetics of macromolecules injected into the subretinal space
Marmor, M. F., Negi, A., & Maurice, D. M. (1985) · Experimental Eye Research · doi:10.1016/0014-4835(85)90138-1 · Cited by 91
Durairaj, C., Shah, J. C., Senapati, S., & Kompella, U. B. (2008) · Pharmaceutical Research · doi:10.1007/s11095-008-9728-7 · Cited by 91
Christoforidis, J. B., Williams, M. M., Wang, J., Jiang, A., Pratt, C., Abdel‐Rasoul, M., Hinkle, G. H., & Knopp, M. V. (2013) · Retina · doi:10.1097/iae.0b013e3182753b12 · Cited by 90
Topical Ocular Drug Delivery to the Back of the Eye by Mucus-Penetrating Particles
Schopf, L. R., Popov, A., Enlow, E. M., Bourassa, J. L., Ong, W., Nowak, P., & Chen, H. (2015) · Translational Vision Science & Technology · doi:10.1167/tvst.4.3.11 · Cited by 85
Vitreous concentration of topically applied brimonidine tartrate 0.2%
Kent, A. R., Nussdorf, J. D., David, R., Tyson, F., Small, D. S., & Fellows, D. (2001) · Ophthalmology · doi:10.1016/s0161-6420(00)00654-0 · Cited by 80
Drug delivery through the sclera: effects of thickness, hydration, and sustained release systems
Lee, S.-B., Geroski, D. H., Prausnitz, M. R., & Edelhauser, H. F. (2003) · Experimental Eye Research · doi:10.1016/s0014-4835(03)00211-2 · Cited by 79
Cruysberg, L. P. J., Nuijts, R. M. M. A., Geroski, D. H., Koole, L. H., Hendrikse, F., & Edelhauser, H. F. (2002) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/108076802321021108 · Cited by 77 · cited 2×
“It is composed of collagen fibers, proteoglycans, and glycoprot ins, creati g a n twork in an aqueous m dium [14,15].”
BackgroundIntravitreal Devices for the Treatment of Vitreous Inflammation
Christoforidis, J. B., Chang, S., Jiang, A., Wang, J., & Cebulla, C. M. (2012) · Mediators of Inflammation · doi:10.1155/2012/126463 · Cited by 77
Kim, S. H., Csaky, K. G., Wang, N. S., & Lutz, R. J. (2007) · Pharmaceutical Research · doi:10.1007/s11095-007-9408-z · Cited by 75
Drug Delivery Implants in the Treatment of Vitreous Inflammation
Wang, J., Jiang, A., Joshi, M., & Christoforidis, J. B. (2013) · Mediators of Inflammation · doi:10.1155/2013/780634 · Cited by 74
Sub-Tenon's administration of local anaesthetic: a review of the technique
Canavan, K. S., Dark, A., & Garrioch, M. (2003) · British Journal of Anaesthesia · doi:10.1093/bja/aeg105 · Cited by 74
Quantitative Determination of the Melanin Contents in Ocular Tissues from Human Blue and Brown Eyes
Menon, I. A., WAKEHAM, D. C., Persad, S., et al. (1992) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/jop.1992.8.35 · Cited by 73
Non-invasive strategies for targeting the posterior segment of eye
Madni, A., Rahem, M. A., Tahir, N., Sarfraz, M., Jabar, A., Rehman, M., Kashif, P. M., Badshah, S. F., Khan, K. U., & Santos, H. A. (2017) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2017.07.065 · Cited by 72
Leeds, J. M., Henry, S. P., Truong, L., Zutshi, A., Levin, A. A., & Kornbrust, D. J. (1997) · PubMed · Cited by 71
Technical brief: subretinal injection and electroporation into adult mouse eyes.
Johnson, C. J., Berglin, L., Chrenek, M. A., Redmond, T. M., Boatright, J. H., & Nickerson, J. M. (2008) · PubMed Central · Cited by 69
Ayalasomayajula, S. P., & Kompella, U. B. (2004) · Pharmaceutical Research · doi:10.1023/b:pham.0000045231.51924.e8 · Cited by 69
Expression, activity and pharmacokinetic impact of ocular transporters
Vellonen, K., Hellinen, L., Mannermaa, E., Ruponen, M., Urtti, A. O., & Kidron, H. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2017.12.009 · Cited by 69
P-Glycoprotein expression in human retinal pigment epithelium cell lines
Constable, P. A., Lawrenson, J. G., Dolman, D. E. M., Arden, G. B., & Abbott, N. J. (2006) · Experimental Eye Research · doi:10.1016/j.exer.2005.10.029 · Cited by 68
EXPERIMENTAL STUDY ON PENICILLIN TREATMENT OF ECTOGENOUS INFECTION OF VITREOUS
Sallmann, L., Meyer, K., & GRANDI, J. D. (1944) · Archives of Ophthalmology · doi:10.1001/archopht.1944.00890090029003 · Cited by 67
Shen, L., You, Y., Sun, S., Chen, Y., Qu, J., & Cheng, L. (2010) · Ophthalmology · doi:10.1016/j.ophtha.2010.03.033 · Cited by 66
Ying, L., Tahara, K., & Takeuchi, H. (2013) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2013.06.024 · Cited by 66
Corrosion casts of the suprachoroidal space and uveoscleral drainage routes in the human eye
Krohn, J., & BERTELSEN, T. I. (1997) · Acta Ophthalmologica Scandinavica · doi:10.1111/j.1600-0420.1997.tb00245.x · Cited by 66
Cefazolin levels after intravitreal injection. Effects of inflammation and surgery.
Ficker, L. A., Meredith, T. A., Gardner, S. K., & Wilson, L. A. (1990) · PubMed · Cited by 64
Subconjunctival Topotecan in Fibrin Sealant in the Treatment of Transgenic Murine Retinoblastoma
Tsui, J. Y., Dalgard, C. L., Quill, K. R. V., Lee, L., Grossniklaus, H. E., Edelhauser, H. F., & O’Brien, J. M. (2008) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.07-0653 · Cited by 63
Permeability of the intraocular blood vessels.
Bill, A., Törnquist, P., & Alm, A. (1980) · PubMed · Cited by 63
Effects of N-trimethylchitosan on transcellular and paracellular transcorneal drug transport
Zambito, Y., Zaino, C., & Colo, G. D. (2006) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2006.01.004 · Cited by 59
Yin, J., & Zhang, J. (2011) · PubMed · doi:10.3969/j.issn.1672-7347.2011.10.002 · Cited by 58
Ocular Pharmacokinetics in Rabbits using a Novel Dual Probe Microdialysis Technique
Macha, S., & Mitra, A. K. (2001) · Experimental Eye Research · doi:10.1006/exer.2000.0953 · Cited by 57
Cytoarchitecture of Choroidal Capillary Endothelial Cells
Guymer, R. H., Bird, A. C., & Hageman, G. S. (2004) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.03-0913 · Cited by 57
Qi, Y., Dai, X., Zhang, H., He, Y., Zhang, Y., Han, J., Zhu, P., Zhang, Y., Zheng, Q., Li, X., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0136523 · Cited by 56
Pitkänen, L., Ranta, V., Moilanen, H., & Urtti, A. O. (2007) · Pharmaceutical Research · doi:10.1007/s11095-007-9342-0 · Cited by 56
Transporters and receptors in ocular drug delivery: opportunities and challenges
Dey, S., & Mitra, A. K. (2005) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2.2.201 · Cited by 56
Intravitreal implantable magnetic micropump for on-demand VEGFR-targeted drug delivery
Wang, C., Seo, S., Kim, J. S., Lee, S., Jeon, J.-K., Kim, J.-W., Kim, K., Kim, J.-K., & Park, J. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2018.05.030 · Cited by 56
Fluorescein dynamics in the eye
Cunha-Vaz, J. G., & Maurice, D. M. (1969) · Documenta Ophthalmologica · doi:10.1007/bf00943962 · Cited by 55
Doxycycline-Mediated Inhibition of Choroidal Neovascularization
Samtani, S., Amaral, J., Campos, M. M., Fariss, R. N., & Becerra, S. P. (2009) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.08-3174 · Cited by 55
Mitra, A. K., Anand, B. S., & Duvvuri, S. (2005) · Advances in organ biology · doi:10.1016/s1569-2590(05)10012-3 · Cited by 53
Choi, Y. J., Oh, I. K., Oh, J., & Huh, K. (2006) · Korean Journal of Ophthalmology · doi:10.3341/kjo.2006.20.4.205 · Cited by 53
Durairaj, C. (2016) · Handbook of experimental pharmacology · doi:10.1007/164_2016_32 · Cited by 53
Gunda, S., Hariharan, S., & Mitra, A. K. (2006) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/jop.2006.22.465 · Cited by 52
Dias, C. S., Anand, B. S., & Mitra, A. K. (2002) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.10072 · Cited by 50
Prediction of Ocular Drug Distribution from Systemic Blood Circulation
Vellonen, K., Soini, E.-M., del Amo, E. M., & Urtti, A. O. (2015) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.5b00729 · Cited by 49
Effects of Inflammation and Surgery on Amikacin Levels in the Vitreous Cavity
Mandell, B. A., Meredith, T. A., Aguilar, E., Elmassry, A., Sawant, A. D., & Gardner, S. K. (1993) · American Journal of Ophthalmology · doi:10.1016/s0002-9394(14)73646-3 · Cited by 48
Krohn, J., & BERTELSEN, T. I. (1998) · Acta Ophthalmologica Scandinavica · doi:10.1034/j.1600-0420.1998.760502.x · Cited by 48
Evaluation of subconjunctival liposomal steroids for the treatment of experimental uveitis
Wong, C. W., Czarny, B., Metselaar, J. M., Ho, C. E. H., Ng, S. R., Barathi, V. A., Storm, G., & Wong, T. T. L. (2018) · Scientific Reports · doi:10.1038/s41598-018-24545-2 · Cited by 47
Boddu, S. H. S., Gunda, S., Earla, R., & Mitra, A. K. (2010) · Bioanalysis · doi:10.4155/bio.10.2 · Cited by 46
Sustained release of intravitreal flurbiprofen from a novel drug-in-liposome-in-hydrogel formulation
Pachis, K. S., Blazaki, S., Tzatzarakis, M. N., Klepetsanis, P. G., Naoumidi, E., Tsilimbaris, M. K., & Antimisiaris, S. G. (2017) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2017.08.028 · Cited by 46
Intravitreal anti-VEGF drug delivery systems for age-related macular degeneration
Luaces-Rodríguez, A., Mondelo‐García, C., Zarra‐Ferro, I., González‐Barcia, M., Aguiar, P., Fernández‐Ferreiro, A., & Otero-Espinar, F. J. (2019) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2019.118767 · Cited by 45
Self-citationPharmacokinetics of Newer Cephalosporins After Subconjunctival and Intravitreal Injection in Rabbits
Barza, M. J. (1993) · Archives of Ophthalmology · doi:10.1001/archopht.1993.01090010125038 · Cited by 44
Penetration of moxifloxacin into the human aqueous humour after oral administration
Kampougeris, G. (2005) · British Journal of Ophthalmology · doi:10.1136/bjo.2004.050054 · Cited by 44
Conrad, J. M., & Robinson, J. R. (1980) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600690806 · Cited by 43
Pharmaceutical microscale and nanoscale approaches for efficient treatment of ocular diseases
Bravo‐Osuna, I., Andrés‐Guerrero, V., Abal, P. P., Molina-Martínez, I. T., & Herrero‐Vanrell, R. (2016) · Drug Delivery and Translational Research · doi:10.1007/s13346-016-0336-5 · Cited by 42
Clearance of Intravitreal Moxifloxacin
Iyer, M. N., He, F., Wensel, T. G., Mieler, W. F., Benz, M. S., & Holz, E. R. (2005) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.05-1124 · Cited by 41
Targeting Inflammation to Improve Tumor Drug Delivery
Gkretsi, V., Zacharia, L. C., & Stylianopoulos, T. (2017) · Trends in cancer · doi:10.1016/j.trecan.2017.07.006 · Cited by 36
Update on the prevention and treatment of endophthalmitis
Schwartz, S. G., & Flynn, H. W. (2014) · Expert Review of Ophthalmology · doi:10.1586/17469899.2014.951331 · Cited by 35
Imai, H., Misra, G. P., Wu, L., Janagam, D. R., Gardner, T. W., & Lowe, T. L. (2015) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.15-16998 · Cited by 35
Wingard, L. B., Zuravleff, J. J., Doft, B. H., et al. (1989) · PubMed · Cited by 31
Spitzer, M. S., Kaczmarek, R. T., Yoeruek, E., Petermeier, K., Wong, D., Heimann, H., Jaissle, G. B., Bartz‐Schmidt, K. U., & Szurman, P. (2009) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.08-2471 · Cited by 30
Principles of Retinal Drug Delivery from Within the Vitreous
WILSON, C. G., Tan, L. E., & Mains, J. (2011) · AAPS advances in the pharmaceutical sciences series · doi:10.1007/978-1-4419-9920-7_6 · Cited by 30
Abrishami, M., Abrishami, M., Mahmoudi, A., Mosallaei, N., Roodi, M. V. A., & Malaekeh‐Nikouei, B. (2016) · Journal of Drug Delivery · doi:10.1155/2016/1368481 · Cited by 29
Dias, C. S., & Mitra, A. K. (2000) · Journal of Pharmaceutical Sciences · doi:10.1002/(sici)1520-6017(200005)89:5<572::aid-jps2>3.0.co;2-p · Cited by 28
The use of biologic therapies in uveitis
Duica, I., Voinea, L., Mitulescu, C., Istrate, S. L., Coman, I.-C., & Ciuluvica, R. C. (2018) · Romanian Journal of Ophthalmology · doi:10.22336/rjo.2018.16 · Cited by 28
Pharmacokinetics and Disposition of Memantine in the Arterially Perfused Bovine Eye
Koeberle, M. J., Hughes, P. M., Skellern, G. G., & WILSON, C. G. (2006) · Pharmaceutical Research · doi:10.1007/s11095-006-9106-2 · Cited by 27
Quantitative study of the topographic distribution of conjunctival lymphatic vessels in the monkey
Guo, W., Zhu, Y., Yu, P. K., Yu, X., Sun, X., Cringle, S. J., Su, E., & Yu, D. (2011) · Experimental Eye Research · doi:10.1016/j.exer.2011.11.011 · Cited by 26
Posterior Juxtascleral Depot Administration of Anecortave Acetate
Kaiser, P. K., Goldberg, M. F., & Davis, A. A. (2007) · Survey of Ophthalmology · doi:10.1016/j.survophthal.2006.10.015 · Cited by 24
Intravitreal injections: A review of pharmacological agents and techniques
Shikari, H., & Samant, P. (2016) · Journal of Clinical Ophthalmology and Research · doi:10.4103/2320-3897.174429 · Cited by 21
Thornit, D. N., Vinten, M., Sander, B., Lund‐Andersen, H., & la Cour, M. (2010) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.09-4172 · Cited by 20
A Review of Antimicrobial Therapy for Infectious Uveitis of the Posterior Segment.
Sallam, A. B., Kirkland, K. A., Barry, R., Soliman, M. K., Ali, T. K., & Lightman, S. (2018) · Medical Hypothesis Discovery & Innovation in Ophthalmology · Cited by 20
Schoenwald, R. D., Tandon, V., Wurster, D. E., & Barfknecht, C. F. (1998) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(97)00166-5 · Cited by 19
Maroñas, O., García‐Quintanilla, L., Luaces-Rodríguez, A., Fernández‐Ferreiro, A., Latorre, A., Abraldes, M. J., Lamas, M. J., & Carracedo, Á. (2019) · Current Medicinal Chemistry · doi:10.2174/0929867326666190711105325 · Cited by 18
Self-citationUtility of transporter/receptor(s) in drug delivery to the eye
Boddu, S. H. S. (2013) · World Journal of Pharmacology · doi:10.5497/wjp.v2.i1.1 · Cited by 15
Krishnamoorthy, M. K., Park, J., Augsburger, J. J., & Banerjee, R. K. (2008) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/jop.2007.0111 · Cited by 13
Ocular Biodistribution Studies Using Molecular Imaging
Castro‐Balado, A., Mondelo‐García, C., González‐Barcia, M., Zarra‐Ferro, I., Otero-Espinar, F. J., Ruibal, Á., Aguiar, P., & Fernández‐Ferreiro, A. (2019) · Pharmaceutics · doi:10.3390/pharmaceutics11050237 · Cited by 13
Self-citationIntravitreal Injection of Octreotide Acetate
Robertson, J. E., Westra, I., Woltering, E. A., Winthrop, K. L., Barrie, R. J., O’Dorisio, T. M., & HOLMES, D. (1997) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/jop.1997.13.171 · Cited by 12
Mehta, S., Laird, P. W., Debiec, M. R., Hwang, C. S., Zhang, R., Yan, J., Hendrick, A. M., Hubbard, G. B., Bergstrom, C. S., Yeh, S., et al. (2017) · Ophthalmology Retina · doi:10.1016/j.oret.2017.07.011 · Cited by 9
Selection of Drug Delivery Approaches for the Back of the Eye: Opportunities and Unmet Needs
Marsh, D. A. (2011) · AAPS advances in the pharmaceutical sciences series · doi:10.1007/978-1-4419-9920-7_1 · Cited by 8
Suprachoroidal injection of ketorolac tromethamine does not cause retinal damage.
Liu, S., Liu, W., Ma, Y., Liu, K., & Wang, M. (2012) · PubMed Central · doi:10.3969/j.issn.1673-5374.2012.35.004 · Cited by 5
Ocular and systemic pharmacokinetic models for drug discovery and development
Páez, D. A., & María, E. S. (2015) · Cited by 2
Cited by
Nanotechnology based drug delivery systems for the treatment of anterior segment eye diseases
Onugwu, A. L., Nwagwu, C. S., Onugwu, O. S., Echezona, A. C., Agbo, C. P., Ihim, S. A., Emeh, P., Nnamani, P. O., Attama, A. A., & Khutoryanskiy, V. V. (2023) · Journal of Controlled Release · doi:10.1016/j.jconrel.2023.01.018 · Cited by 350
Nanotechnology-based ocular drug delivery systems: recent advances and future prospects
Li, S., Chen, L., & Fu, Y. (2023) · Journal of Nanobiotechnology · doi:10.1186/s12951-023-01992-2 · Cited by 277
Ocular Drug Delivery to the Retina: Current Innovations and Future Perspectives
Kim, H. M., & Woo, S. J. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13010108 · Cited by 198
Subretinal injection techniques for retinal disease: A review
Irigoyen, C., Amenabar Alonso, A., Sanchez-Molina, J., Rodríguez-Hidalgo, M., Lara-López, A., & Ruiz-Ederra, J. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11164717 · Cited by 106
Lipid nanoparticles for the posterior eye segment
Bonilla, L., Espina, M., Severino, P., Cano, A., Ettcheto, M., Camins, A., García, M. L., Souto, E. B., & Sánchez-López, E. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics14010090 · Cited by 76
Metadata
- Authors
- Varela-Fernández, R., Díaz-Tomé, V., Luaces-Rodríguez, A., Conde-Penedo, A., García-Otero, X., Luzardo-Álvarez, A., Fernández-Ferreiro, A., & Otero-Espinar, F.
- Venue
- Pharmaceutics
- Publisher
- MDPI AG
- Published
- 2020-03-16
- Volume
- 12
- Issue
- 3
- Pages
- 269
- ISSN
- 1999-4923 (ISSN-L)
- OpenAlex
- W3011522762
- Cited by
- 354
- References
- 173
- FWCI
- 15.59
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.